| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ΠΠ°ΡΠΊΠ΅Ρ (Rus) | Marker (Eng) | Marker's characteristics | Aging Diagnostic Approach | ΠΠ°ΡΠΊΠ΅Ρ ΡΠΎΠ»ΡΠΊΠΎ Π² 1 ΠΏΠ°Π½Π΅Π»ΠΈ | 1 | ΠΠΎΡΡΠ½Π΅Π½ΠΈΠ΅ ΠΏΡΠΎ β: Π»ΠΈΠ±ΠΎ ΠΏΠΎΡΠΎΠΌΡ ΡΡΠΎ Π΄Π°Π½Π½Π°Ρ ΠΏΠ°Π½Π΅Π»Ρ β ΡΡΠΎ ΠΏΠΎΠ΄ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²ΠΎ Π΄ΡΡΠ³ΠΎΠΉ ΠΏΠ°Π½Π΅Π»ΠΈ, ΠΊΠ°ΠΊ Π΄Π»Ρ ΠΏΠ°Π½Π΅Π»Π΅ΠΉ Π’Π΅ΡΠ°Π½ΠΎΡΡΠΈΠΊΠΈ, Π³Π΄Π΅ "ΡΠ°ΠΊ", "ΠΌΠΎΠ·Π³ ΠΈ Π΄Π΅ΠΏΡΠ΅ΡΡΠΈΡ" ΠΈ "ΡΠ΅ΡΠ΄ΡΠ΅ ΠΈ ΡΠΎΡΡΠ΄Ρ" β ΠΏΠΎΠ΄ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π° FULL, Π»ΠΈΠ±ΠΎ ΠΏΠ°Π½Π΅Π»Ρ Π½Π΅ Π²ΡΠ·ΡΠ²Π°Π΅Ρ ΠΏΠΎΠΊΠ° Π΄ΠΎΠ²Π΅ΡΠΈΠ΅, ΠΊΠ°ΠΊ ΠΏΠ°Π½Π΅Π»Ρ Π² ΠΠ GDF11. | ||||||||||||||||||||||||||||
2 | What's that in general? | Type of a marker | System, organ, process | Which of the 9 Hallmarks of Aging it tracks | Cytokine | Panel Inclusion ranking | Epigenetic | Frailty Index | Singapore Panel | Chinese Panel | British Panel | SENS | SASP | TAME (by Nir Barzilai) | GDF11 "trial" | Open Longevity | ΠΠ°ΡΠΊΠ΅Ρ Π² 2 ΠΏΠ°Π½Π΅Π»ΡΡ | 2 | |||||||||||||||||
3 | Horvath Clock (IEAA) | Hannum Clock | DNAm PhenoAge | OL 1.4 | Theranostic 1.1 | ΠΠ°ΡΠΊΠ΅Ρ Π² 3 ΠΏΠ°Π½Π΅Π»ΡΡ | 3 | ||||||||||||||||||||||||||||
4 | https://habr.com/ru/post/428377/ | https://habr.com/ru/post/419721/ | https://habr.com/ru/post/420259/ | https://habr.com/ru/post/424399/ | https://habr.com/ru/post/423979/ | https://habr.com/ru/post/421225/ | https://www.ncbi.nlm.nih.gov/pubmed/19053174 | https://gdf11rejuvenation.com/doctors-biomarkers | Basic | Pro | New | FULL | Oncology | Brain & Depression | Heart & Vessels | ΠΠ°ΡΠΊΠ΅Ρ Π² 4 ΠΏΠ°Π½Π΅Π»ΡΡ | 4 | ||||||||||||||||||
5 | https://habr.com/ru/post/421875/ | ΠΠ°ΡΠΊΠ΅Ρ Π² 5 ΠΏΠ°Π½Π΅Π»ΡΡ | 5 | ||||||||||||||||||||||||||||||||
6 | https://habr.com/ru/post/422125/ | ΠΠ°ΡΠΊΠ΅Ρ Π² 6 ΠΏΠ°Π½Π΅Π»ΡΡ | 6 | ||||||||||||||||||||||||||||||||
7 | https://habr.com/ru/post/419819/ | https://habr.com/ru/post/423009/ | https://gdf11rejuvenation.com/daily-trending-biomarkers | http://openlongevity.org/diagnostics | ΠΠ°ΡΠΊΠ΅Ρ Π² 7 ΠΏΠ°Π½Π΅Π»ΡΡ | 7 | |||||||||||||||||||||||||||||
8 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836174/figure/F1/ | https://habr.com/en/post/427029/ | https://docs.google.com/spreadsheets/d/16oGboYHa7szNRtCs5ALVNWFBSAsUacKra9fBfKdByDE/edit#gid=0 | https://dnkom.ru/analizy-i-tseny/diagnostika-stareniya-open-longevity/teranostika-1-1-full/ | https://dnkom.ru/analizy-i-tseny/diagnostika-stareniya-open-longevity/teranostika-1-1-rak/ | https://dnkom.ru/analizy-i-tseny/diagnostika-stareniya-open-longevity/teranostika-1-1-mozg-i-depressiya/ | https://dnkom.ru/analizy-i-tseny/diagnostika-stareniya-open-longevity/teranostika-1-1-serdtse-i-sosudy/ | ΠΠ°ΡΠΊΠ΅Ρ ΠΏΡΠΎΡΡΠΎ Π΅ΡΡΡ Π² ΠΏΠ°Π½Π΅Π»ΠΈ, ΠΏΠ°Π½Π΅Π»Ρ Π½Π΅ ΡΡΠΈΡΡΠ²Π°Π΅ΡΡΡ Π² ΠΏΠΎΠ΄ΡΡΡΡΠ΅ | β | ||||||||||||||||||||||||||
9 | Total number of markers in a panel β> | 353 | 71 | 9 | 41 | 26 | 36 | 56 | 32 | 27 | 10 | 21 | 41 | 49 | 14 | 51 | 19 | 25 | 28 | ||||||||||||||||
10 | Π€ΠΎΡΡΠΎΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ Π³ΠΈΡΡΠΎΠ½ Ξ³H2AX | Phosphorylated Histone Ξ³H2AX | Molecular | DNA | 2 | 2 | 2 | ||||||||||||||||||||||||||||
11 | ΠΠ»ΠΈΠ½Π° ΡΠ΅Π»ΠΎΠΌΠ΅Ρ | Telomere length | Molecular | DNA | 1 | 1 | |||||||||||||||||||||||||||||
12 | ΠΠ»ΠΈΠ½Π° ΡΠ΅Π»ΠΎΠΌΠ΅Ρ Π»Π΅ΠΉΠΊΠΎΡΠΈΡΠΎΠ² | Leukocyte telomere length | Molecular | DNA | 1 | 1 | |||||||||||||||||||||||||||||
13 | ΠΠ΅ΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΠΠ | DNA methylation | Molecular | DNA | 3 | 353 CpG ΡΠ°ΠΉΡΠ° ΠΌΠ΅ΡΠΈΠ»Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΠΠ | 71 CpG ΡΠ°ΠΉΡ ΠΌΠ΅ΡΠΈΠ»Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΠΠ | 3 | |||||||||||||||||||||||||||
14 | ΠΠ½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½Π°Ρ ΡΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠ°Ρ ΠΠΠ (Π²ΠΊΠΠΠ) | Π‘ell-free DNA (also known as circulating DNA) | Molecular | DNA | 1 | 1 | |||||||||||||||||||||||||||||
15 | Π€Π΅Π½ΠΎΡΠΈΠΏ Π’-ΠΊΠ»Π΅ΡΠΎΠΊ | T cell phenotype | Molecular | RNAi transcription | 1 | 1 | |||||||||||||||||||||||||||||
16 | ΠΠ΅ΡΠ΅ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΡ CD38 Π² CD4 +CD27 + Π’-ΠΊΠ»Π΅ΡΠΊΠ°Ρ | CD38 heterogeneity in CD4 + CD27 + T cells | Molecular | RNAi transcription | 1 | 1 | |||||||||||||||||||||||||||||
17 | ΠΠ΅ΡΠ΅ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΡ CD197 Π² CD4 +CD25 + T-ΠΊΠ»Π΅ΡΠΊΠ°Ρ | CD197 heterogeneity in CD4 + CD25 + T cells | Molecular | RNAi transcription | 1 | 1 | |||||||||||||||||||||||||||||
18 | Π¦ΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠΈΠ΅ ΠΌΠΈΠΊΡΠΎΠ ΠΠ (miR-34a, miR-21, miR-126-3p, miR-151a-3p, miR-181a-5p, miR-1248) | Circulating miRNAs (miR-34a, miR-21, miR-126-3p, miR-151a-3p, miR-181a-5p, miR-1248) | Molecular | RNAi transcription | 2 | 2 | 2 | ||||||||||||||||||||||||||||
19 | ΠΠ»ΠΈΠ½Π½ΡΠ΅ Π½Π΅ΠΊΠΎΠ΄ΠΈΡΡΡΡΠΈΠ΅ Π ΠΠ (MIR31HG, AK156230, Meg3) | Long non-coding RNA (MIR31HG, AK156230, Meg3) | Molecular | RNAi transcription | 1 | 1 | |||||||||||||||||||||||||||||
20 | ΠΠΎΡΠΌΠΎΠ½ ΡΠΎΡΡΠ° | Growth factor (GF) | Molecular | Metabolism | 3 | 3 | 3 | 3 | |||||||||||||||||||||||||||
21 | Klotho | Klotho | Molecular | Metabolism | 1 | 1 | β | ||||||||||||||||||||||||||||
22 | Π€Π°ΠΊΡΠΎΡ ΡΠΎΡΡΠ° ΡΠΈΠ±ΡΠΎΠ±Π»Π°ΡΡΠΎΠ² 21 | Fibroblast growth factor 21 (FGF21) | Molecular | Metabolism | 1 | 1 | |||||||||||||||||||||||||||||
23 | Π Π΅Π·ΠΈΡΡΠΈΠ½ | Resistin (RETN) | Molecular | Metabolism | 2 | 2 | 2 | ||||||||||||||||||||||||||||
24 | ΠΠ΄ΠΈΠΏΠΎΠ½Π΅ΠΊΡΠΈΠ½ | Adiponectin (ADIPOQ) | Molecular | Metabolism | 2 | 2 | 2 | ||||||||||||||||||||||||||||
25 | mTOR | mTOR | Molecular | Metabolism | 2 | 2 | 2 | ||||||||||||||||||||||||||||
26 | pS6RP | pS6RP | Molecular | Metabolism | 1 | 1 | |||||||||||||||||||||||||||||
27 | NAD +, SIRT1, SIRT2, SIRT3, SIRT6 | NAD +, SIRT1, SIRT2, SIRT3, SIRT6 | Molecular | Metabolism | 1 | 1 | |||||||||||||||||||||||||||||
28 | ΠΠ°ΡΠ±Π°ΠΌΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π±Π΅Π»ΠΊΠΎΠ² | Protein carbamylation | Molecular | Metabolism | 1 | 1 | |||||||||||||||||||||||||||||
29 | ΠΠΠ ΠΈ N-Π³Π»ΠΈΠΊΠ°Π½Ρ | Glycation end products and N-glycans | Molecular | Metabolism | 1 | 1 | |||||||||||||||||||||||||||||
30 | ΠΠ»ΠΈΠΊΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½ | Glycosylated hemoglobin (HbAΠ‘1) | Molecular | Glucose metabolism | 3 | 3 | 3 | β | β | β | 3 | β | β | ||||||||||||||||||||||
31 | ΠΠ»ΡΠΊΠΎΠ·Π° | Glucose | Molecular | Glucose metabolism | 2 | 2 | 2 | ||||||||||||||||||||||||||||
32 | ΠΠ»ΡΠΊΠΎΠ·Π° Π½Π°ΡΠΎΡΠ°ΠΊ | Fasting plasma glucose | Molecular | Glucose metabolism | 2 | 2 | β | β | β | 2 | β | β | β | ||||||||||||||||||||||
33 | ΠΠ½ΡΡΠ»ΠΈΠ½ | Insulin | Molecular | Glucose metabolism | 3 | 3 | 3 | β | β | β | 3 | β | β | β | |||||||||||||||||||||
34 | ΠΠΈΠΎΡ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ | Biochemistry assay | Molecular | Glucose metabolism | 1 | 1 | |||||||||||||||||||||||||||||
35 | S100 ΠΊΠ°Π»ΡΡΠΈΠΉ-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ Π±Π΅Π»ΠΎΠΊ B | S100 calcium binding protein B (S100B) | Molecular | Calcium homeostasis | 1 | 1 | |||||||||||||||||||||||||||||
36 | Π Π΅Π³ΡΠΊΠ°Π»ΡΡΠΈΠ½ (ΠΠ°ΡΠΊΠ΅Ρ ΡΡΠ°ΡΠ΅Π½ΠΈΡ protein-30) | Regucalcin (RGN) (Senescence marker protein-30, SMP30) | Molecular | Calcium homeostasis | 1 | 1 | |||||||||||||||||||||||||||||
37 | ΠΠ°Π»ΡΡΠ΅ΡΠΈΠΊΡΠ»ΠΈΠ½ | Calreticulin (CALR) | Molecular | Calcium homeostasis | 1 | 1 | |||||||||||||||||||||||||||||
38 | ΠΎ-ΡΠΈΡΠΎΠ·ΠΈΠ½ | o-tyrosine | Molecular | Oxidative stress, mitochondria and apoptosis | 2 | 2 | 2 | ||||||||||||||||||||||||||||
39 | 3-Ρ Π»ΠΎΡΡΠΈΡΠΎΠ·ΠΈΠ½ | 3-chlorothyrosine | Molecular | Oxidative stress, mitochondria and apoptosis | 2 | 2 | 2 | ||||||||||||||||||||||||||||
40 | 3-Π½ΠΈΡΡΠΎΡΠΈΡΠΎΠ·ΠΈΠ½ | 3-nitrotyrosine | Molecular | Oxidative stress, mitochondria and apoptosis | 2 | 2 | 2 | ||||||||||||||||||||||||||||
41 | 8-ΠΈΠ·ΠΎΠΏΡΠΎΡΡΠ°Π½ | 8-isoprostane (8-ISO) | Molecular | Oxidative stress, mitochondria and apoptosis | 3 | 3 | 3 | 3 | |||||||||||||||||||||||||||
42 | 8-Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈ-2'-Π΄Π΅Π·ΠΎΠΊΡΠΈΠ³ΡΠ°Π½ΠΎΠ·ΠΈΠ½ | 8-OHdG | Molecular | Oxidative stress, mitochondria and apoptosis | 2 | 2 | 2 | ||||||||||||||||||||||||||||
43 | 8-Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈΠ³ΡΠ°Π½ΠΎΠ·ΠΈΠ½ | 8-OHG | Molecular | Oxidative stress, mitochondria and apoptosis | 2 | 2 | 2 | ||||||||||||||||||||||||||||
44 | ΠΡΠΈΠ·ΠΈΠ½ | Fibronectin type III domain containing 5 (FNDC5) (Irisin) | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
45 | ΠΠΈΠΌΠ΅Π½ΡΠΈΠ½ | Vimentin (VIM) | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
46 | ΠΠ°Π»ΠΎΠ½ΠΎΠ²ΡΠΉ Π΄ΠΈΠ°Π»ΡΠ΄Π΅Π³ΠΈΠ΄ | Malonic dialdehyde | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
47 | ΠΡΠΎΠ΄ΡΠΊΡΡ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² | Protein Oxidation Products (AOPP) | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
48 | ΠΠ»Π΅ΡΠΎΡΠ½Π°Ρ ΠΌΡΠΠΠ (Π΅Ρ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΈ Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΌΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² Ρ Π΄Π΅Π»Π΅ΡΠΈΡΠΌΠΈ) | Cellular mtDNA (its number and the presence of mutated variants with deletions) | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
49 | ΠΠ»ΡΡΠ°ΡΠΈΠΎΠ½ | Glutathione | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
50 | Π¦ΠΈΡΡΠ΅ΠΈΠ½ | Cysteine | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
51 | ΠΠΎΡΠ΅Π²Π°Ρ ΠΊΠΈΡΠ»ΠΎΡΠ° | Uric acid | Molecular | Oxidative stress, mitochondria and apoptosis | 2 | 2 | β | β | 2 | β | |||||||||||||||||||||||||
52 | Π£Π±ΠΈΡ ΠΈΠ½ΠΎΠ» | Ubiquinol | Molecular | Oxidative stress, mitochondria and apoptosis | 1 | 1 | |||||||||||||||||||||||||||||
53 | ΠΠ°ΡΠ±ΠΎΠΊΡΠΈΠΌΠ΅ΡΠΈΠ»-Π»ΠΈΠ·ΠΈΠ½ (ΠΠΠ) | Carboxymethyl-lysine (CML) | Molecular | Protein glycation | 1 | 1 | β | ||||||||||||||||||||||||||||
54 | ΠΠ»ΡΠΊΠΎΠ·Π΅ΠΏΠ°Π½ | Glucosepane | Molecular | Protein glycation | 1 | 1 | |||||||||||||||||||||||||||||
55 | DOGDIC | DOGDIC | Molecular | Protein glycation | 1 | 1 | |||||||||||||||||||||||||||||
56 | MODIC | MODIC | Molecular | Protein glycation | 1 | 1 | |||||||||||||||||||||||||||||
57 | GODIC | GODIC | Molecular | Protein glycation | 1 | 1 | |||||||||||||||||||||||||||||
58 | GOLD | GOLD | Molecular | Protein glycation | 1 | 1 | |||||||||||||||||||||||||||||
59 | MOLD | MOLD | Molecular | Protein glycation | 1 | 1 | |||||||||||||||||||||||||||||
60 | ΠΠΌΠΈΠ»ΠΎΠΈΠ΄ ΠΞ²-42 | Amyloid AΞ²-42 | Molecular | Protein aggregates | 1 | 1 | |||||||||||||||||||||||||||||
61 | ΠΠ±ΡΠΈΠΉ Ο-Π±Π΅Π»ΠΎΠΊ | Total Ο-protein | Molecular | Protein aggregates | 1 | 1 | |||||||||||||||||||||||||||||
62 | Π€ΠΎΡΡΠΎΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ Ο-Π±Π΅Π»ΠΎΠΊ | Phosphorylated Ο-protein | Molecular | Protein aggregates | 1 | 1 | |||||||||||||||||||||||||||||
63 | ΠΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½Π°Ρ Ρ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌ ΡΡΠ°ΡΠ΅Π½ΠΈΠ΅ΠΌ Ξ²-Π³Π°Π»Π°ΠΊΡΠΎΠ·ΠΈΠ΄Π°Π·Π° | Associated with cellular aging Ξ²-galactosidase (SA-Ξ²-Gal) | Molecular | Cell senescence | 2 | 2 | 2 | ||||||||||||||||||||||||||||
64 | ΠΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Ρ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌ ΡΡΠ°ΡΠ΅Π½ΠΈΠ΅ΠΌ Π³Π΅ΡΠ΅ΡΠΎΡ ΡΠΎΠΌΠ°ΡΠΈΠ½ΠΎΠ²ΡΠ΅ ΡΠΎΠΊΡΡΡ | Heterochromatin foci associated with cellular aging (SAHF) | Molecular | Cell senescence | 1 | 1 | |||||||||||||||||||||||||||||
65 | ΠΠ΅Π»ΠΎΠΊ p16INK4A | p16INK4A | Molecular | Cell senescence | 2 | 2 | 2 | ||||||||||||||||||||||||||||
66 | ΠΠΈΠΏΠΎΡΡΡΡΠΈΠ½ | Lipofuscin | Molecular | Cell senescence | 1 | 1 | |||||||||||||||||||||||||||||
67 | Π‘Π²ΡΠ·Π°Π½Π½ΡΠΉ ΡΠΎ ΡΡΠ°ΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ΅ΠΊΡΠ΅ΡΠΎΡΠ½ΡΠΉ ΡΠ΅Π½ΠΎΡΠΈΠΏ | Senescence associated secretory phenotype (SASP) | Molecular | Inflammation and intercellular communication | 1 | 1 | |||||||||||||||||||||||||||||
68 | CD14 Π°Π½ΡΠΈΠ³Π΅Π½ | CD14 antigen | Molecular | Inflammation and intercellular communication | 1 | 1 | |||||||||||||||||||||||||||||
69 | Π€ΡΠ°ΠΊΡΠ°Π»ΠΊΠΈΠ½ CX3CL1 | Fractalquin (CX3CL1) | Molecular | Inflammation and intercellular communication | 1 | 1 | |||||||||||||||||||||||||||||
70 | ΠΠ΅Π½ΡΡΠ°ΠΊΡΠΈΠ½ | Pentraxin (PTX3) | Molecular | Inflammation and intercellular communication | 1 | 1 | |||||||||||||||||||||||||||||
71 | ΠΠΎΠ»Π΅ΠΊΡΠ»Ρ Π°Π΄Π³Π΅Π·ΠΈΠΈ sVCAM/sICAM | Adhesion molecules sVCAM/sICAM | Molecular | Inflammation and intercellular communication | 2 | 2 | 2 | ||||||||||||||||||||||||||||
72 | ΠΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½ 6 | Interleukin 6 (IL-6) | Molecular | Inflammation and intercellular communication | pro-inflammatory | 7 | 7 | 7 | 7 | 7 | 7 | 7 | β | β | 7 | β | |||||||||||||||||||
73 | ΠΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ Π³Π°ΠΌΠΌΠ° ΠΈΠ½Π΄ΡΡΠΈΠ±Π΅Π»ΡΠ½ΡΠΉ Π±Π΅Π»ΠΎΠΊ (IP-10) (ΠΎΠ½ ΠΆΠ΅ CXCL10 C-X-C motif chemokine 10) | Interferon gamma inducible protein IP-10 (also known as CXCL10 C-X-C motif chemokine 10) | Molecular | Inflammation and intercellular communication | 2 | 2 | 2 | ||||||||||||||||||||||||||||
74 | Π’ΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΡΡΡΠΈΠΉ ΡΠΎΡΡΠΎΠ²ΠΎΠΉ ΡΠ°ΠΊΡΠΎΡ Π±Π΅ΡΠ° | Transforming growth factor-Ξ² (TGF-Ξ²) | Molecular | Fibrosis | anti-inflammatory | 2 | 2 | 2 | β | ||||||||||||||||||||||||||
75 | ΠΠ½Π³ΠΈΠ±ΠΈΡΠΎΡ Π°ΠΊΡΠΈΠ²Π°ΡΠΎΡΠ° ΠΏΠ»Π°Π·ΠΌΠΈΠ½ΠΎΠ³Π΅Π½Π° 1 | Plasminogen activator inhibitor 1 (PAI-1)(also known as Serpine E1) | Molecular | Fibrosis | 2 | 2 | 2 | ||||||||||||||||||||||||||||
76 | Π£ΡΠΎΠΊΠΈΠ½Π°Π·Π½ΡΠΉ Π°ΠΊΡΠΈΠ²Π°ΡΠΎΡ ΠΏΠ»Π°Π·ΠΌΠΈΠ½ΠΎΠ³Π΅Π½Π° | Urokinase plasminogen activator (uPA) | Molecular | Fibrosis | 2 | 2 | 2 | ||||||||||||||||||||||||||||
77 | Π’ΠΊΠ°Π½Π΅Π²ΡΠΉ Π°ΠΊΡΠΈΠ²Π°ΡΠΎΡ ΠΏΠ»Π°Π·ΠΌΠΈΠ½ΠΎΠ³Π΅Π½Π° | tPA | 1 | 1 | |||||||||||||||||||||||||||||||
78 | ΠΠ°ΡΡΠΈΠΊΡΠ½Π°Ρ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Π°-1 | Matrix metalloproteinases (MMP-1) | 1 | 1 | |||||||||||||||||||||||||||||||
79 | ΠΠ°ΡΡΠΈΠΊΡΠ½Π°Ρ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Π°-3 | Matrix metalloproteinases (MMP-3) | 1 | 1 | |||||||||||||||||||||||||||||||
80 | ΠΠ°ΡΡΠΈΠ»ΠΈΠ·ΠΈΠ½, ΠΌΠ°ΡΡΠΈΠΊΡΠ½Π°Ρ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Π°-7 | Matrix metalloproteinases (MMP-7) | Molecular | Fibrosis | 1 | 1 | |||||||||||||||||||||||||||||
81 | ΠΠ°ΡΡΠΈΠΊΡΠ½Π°Ρ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Π°-9 | Matrix metalloproteinases (MMP-9) | Molecular | Fibrosis | 1 | β | |||||||||||||||||||||||||||||
82 | ΠΠ°ΡΡΠΈΠΊΡΠ½Π°Ρ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Π°-10 | Matrix metalloproteinases (MMP-10) | 1 | 1 | |||||||||||||||||||||||||||||||
83 | Π’ΡΠ°Π½ΡΠ³Π»ΡΡΠ°ΠΌΠΈΠ½Π°Π·Π° 2 | Transglutaminase 2 (TGM2) | Molecular | Fibrosis | 1 | 1 | |||||||||||||||||||||||||||||
84 | Π’ΡΠΎΠΌΠ±ΠΎΡΠΏΠΎΠ½Π΄ΠΈΠ½-2 | Thrombospondin-2 (THBS2) | Molecular | Fibrosis | 1 | 1 | |||||||||||||||||||||||||||||
85 | ΠΠ½Π³ΠΈΠΎΡΠ΅Π½Π·ΠΈΠ½ΠΎΠ³Π΅Π½ | Angiotensinogen (AGT) | Molecular | Fibrosis | 1 | 1 | |||||||||||||||||||||||||||||
86 | ΠΠ΅ΠΉΡΠΎΡΡΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ°ΠΊΡΠΎΡ ΠΌΠΎΠ·Π³Π° | Brain neurotrophic factor (BDNF) | Molecular | Neurons and neuromuscular junction | 1 | 1 | |||||||||||||||||||||||||||||
87 | ΠΠ³ΡΠΈΠ½ | Agrin (AGRN) | Molecular | Neurons and neuromuscular junction | 1 | 1 | |||||||||||||||||||||||||||||
88 | ΠΡΠΎΠ³ΡΠ°Π½ΡΠ»ΠΈΠ½ | Progranulin (PGRN) | Molecular | Neurons and neuromuscular junction | 1 | 1 | |||||||||||||||||||||||||||||
89 | ΠΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΌΠ΅Π½ΡΠ° C3 ΠΈ C1q | Complement factor 3 and 1Q (C3 ΠΈ C1q) | Molecular | Neurons and neuromuscular junction | 1 | 1 | |||||||||||||||||||||||||||||
90 | Π Π΅ΡΠ΅ΠΏΡΠΎΡ AGER | Advanced glycosylation end-product specific receptor (AGER) | Molecular | Neurons and neuromuscular junction | 1 | 1 | |||||||||||||||||||||||||||||
91 | ΠΠ΅Π»ΠΎΠΊ HMGB1 (high mobility group box 1) | High mobility group box 1 (HMGB1) | Molecular | Neurons and neuromuscular junction | 2 | 2 | 2 | ||||||||||||||||||||||||||||
92 | Π Π°ΡΡΠ²ΠΎΡΠΈΠΌΡΠΉ ΡΡΠΏΡΠ΅ΡΡΠΎΡ ΡΡΠΌΠΎΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ ST2 | Soluble suppression of tumorigenicity 2 (ST2) | Molecular | Neurons and neuromuscular junction | 1 | 1 | |||||||||||||||||||||||||||||
93 | ΠΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½-8 | Interleukin-8 (IL-8) | Molecular | All-cause mortality | pro-inflammatory | 2 | 2 | 2 | |||||||||||||||||||||||||||
94 | ΠΡΡΠ΅ΠΎΠΏΡΠΎΡΠ΅Π³Π΅ΡΠΈΠ½ | Osteoprotegerin (OPG) | Molecular | All-cause mortality | 1 | 1 | |||||||||||||||||||||||||||||
95 | Π€Π°ΠΊΡΠΎΡ ΡΡΠ²ΠΎΠ»ΠΎΠ²ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ | Stem cell factor (SCF) | Molecular | All-cause mortality | 1 | 1 | |||||||||||||||||||||||||||||
96 | ΠΠ»ΡΠΊΠ°Π³ΠΎΠ½ΠΎΠΏΠΎΠ΄ΠΎΠ±Π½ΡΠΉ ΠΏΠ΅ΠΏΡΠΈΠ΄-1 | Glucagon-like peptide-1 (GLP-1) | Molecular | All-cause mortality | 1 | 1 | |||||||||||||||||||||||||||||
97 | Π€Π°ΠΊΡΠΎ Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ Π€ΠΠ-Ξ± | Facto necrosis of tumors (TNF-Ξ±-R) | Molecular | All-cause mortality | 2 | 2 | 2 | ||||||||||||||||||||||||||||
98 | ΠΠΎΡΠ°ΠΊΡΠΈΠ½ | Eotaxin | Molecular | All-cause mortality | 1 | 1 | |||||||||||||||||||||||||||||
99 | Π₯Π΅ΠΌΠΎΠΊΠΈΠ½ IP-10 | Chemokine IP-10 | Molecular | All-cause mortality | 1 | 1 | |||||||||||||||||||||||||||||
100 | ΠΠΎΠΆΠ½ΡΠΉ Ρ Π΅ΠΌΠΎΠΊΠΈΠ½, ΠΏΡΠΈΠ²Π»Π΅ΠΊΠ°ΡΡΠΈΠΉ Π’-ΠΊΠ»Π΅ΡΠΊΠΈ (CTACK) | Cutaneous chemokine attracting T-cells (CTACK) | Molecular | All-cause mortality | 1 | 1 | |||||||||||||||||||||||||||||